I. Kelbel et al., Effects of parenteral application of fish oil versus soy oil emulsions on bacterial clearance functions, INFUSIONSTH, 26(4), 1999, pp. 226-232
Background: The aim of this study was to test whether or not infusion of tr
iglycerides containing omega-3 fatty acids (FAs) modifies immune function i
n terms of systemic clearance and organ distribution of injected Escherichi
a coli in a rabbit model. Materials and Methods: In groups of 6 rabbits eac
h, a defined number of E. coli (1.3 x 10(8) colony-forming units, CFU) was
injected intravenously after 3 days of infusion with a lipid emulsion prepa
red from fish oil (Omega-venos(R)10%, 1.5 g/kg body weight/day), a soy oil
preparation (Lipovenos(R)10%, 1.5 g/kg body weight/day), or after isotonic
saline application (control). In order to compare dose-de pendent effects,
in a second experimental design a lower dose of each lipid emulsion (0.5 g/
kg body weight) was infused over a 4-hour period before applicating E. coli
. Parameters monitored were arterial pressure and rates of bacterial elimin
ation from the blood. The animals were killed 3 h and 6 h after bacterial i
nfection, respectively, and tissue samples of liver, spleen, lung, and kidn
ey were collected for microbiological examinations. Results: Lipovenos infu
sion produced a significant delay in blood clearance compared with saline a
nd Omegavenos treatment. The diminished systemic bacterial elimination afte
r Lipovenos infusion was accompanied by increased numbers af viable bacteri
a in lung and spleen. In contrast to this, in the Omegavenos group bacteria
l counts in the lung did not increase and smaller amounts of viable bacteri
a were detected in organ homogenates 6 h after injection of E. coli Conclus
ion: Compared with the soy oil preparation, omega-3 FAs induce improved bac
terial clearance from the blood that is associated with significantly lower
numbers of E. coli in the lung. Thus, appropriate nutrition providing omeg
a-3 FA might serve as a pharmacological tool to improve host defence agains
t bacterial infection in critically ill patients.